Cardiovascular Outcomes Registry in Cardiogenic SHOCK (COR-SHOCK)
Recruiting
Observational Study
Cardiogenic Shock Acute
Cardiogenic Shock
Cardiogenic Shock Post Myocardial Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 800 (estimated)
- Sponsor
- Hospital de Santa Cruz, Portugal · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to evaluate the clinical outcomes and management approaches of cardiogenic shock throughout the years in adult patients admitted to a Cardiology Department. The main questions it aims to answer are:
* How have management strategies and clinical outcomes for cardiogenic shock evolved over time?
* How do clinical, laboratory, and advanced hemodynamic monitori…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
-Cardiogenic shock according to the following criteria:
Cardiac disorder resulting in hypotension, defined as at least one of the following:
* Systolic blood pressure (SBP) \<90 mmHg for ≥30 minutes, or
* Requirement for vasopressors, inotropes, or mechanical circulatory suppo…
Contacts